Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media
21 October 2015

Jayasree K. Iyer becomes Executive Director of the Access to Medicine Foundation

As of October, 2015, Jayasree K. Iyer is Executive Director of the Access to Medicine Foundation, taking over from Wim Leereveld. Wim Leereveld will join the Foundation’s Supervisory Board.

“Since joining the Foundation in 2013, Jay has added tremendous depth to the Foundation’s research and our dialogue with the many stakeholders working in access to medicine,” says Wim Leereveld, Founder of the Access to Medicine Foundation. “I am very proud that Jay will lead the organisation as it takes the idea of ranking pharmaceutical companies to the next level.” After 12 years as CEO, Wim now joins the Foundation’s Supervisory Board. 

A list of ambitious but achievable actions 

Wim Leereveld founded the Access to Medicine Foundation in 2003. “I started with a single idea: how can we encourage the pharmaceutical industry to do more to help the world’s poorest people access the medicine they need? Working with experts in the field and from industry, we built a list of ambitious but achievable actions for pharmaceutical companies to take. In 2008, this list formed the basis of the first Access to Medicine Index.” Since then, the Index has grown into a leading sustainability Index for the pharmaceutical industry.

“How to make a difference”

Since 2013, Jay Iyer has built up the Foundation’s in-house research expertise and leads the development and application of its methodology for measuring pharmaceutical company behaviour. As a spokesperson, she is actively involved in stimulating change within the pharmaceutical industry. She plays a central role in the Foundation’s discussions with companies, governments and investors, among others. Jay has worked at the interface of the global health community and the pharmaceutical industry for 12 years, including in public-private partnerships for infectious diseases and oncology. She has worked at various NGOs, academic institutions and think tanks.

“I am honoured to lead the Access to Medicine Foundation,” says Jay Iyer. “The Foundation is recognised as a leading metrics maker for the pharmaceutical industry, and we know that companies act on our insights. Thank you to Wim and to the Foundation’s incredibly dedicated team for bringing this idea so far. Demand for our expertise continues to grow. We will bring specific opportunities for each company to lead on – where to innovate, how to reach the poor, and where to make a difference.”

Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved